Approval of first interchangeable biosimilar insulin to increase competition with payer contracts:… EP News Bureau Aug 26, 2021 While patients will be increasingly prescribed Viatris/Biocon’s Semglee over Sanofi’s Lantus due to its competitive pricing,…
